Top 10 Diversified Bank Stocks To Watch Right Now

Despite ongoing debate regarding guns and public safety, firearms seem to be a popular as ever.

Today, Americans own an all-time high of 310 million guns; that figure rises at a 10% clip per year. That�� double the number owned in 1968 and includes handguns, rifles and shotguns.

The gun industry�� economic impact on the United States is a staggering $31.8 billion per year, which, The Christian Science Monitor pointed out, is ��ess than 1% of the U.S. gross domestic product, about what Americans spend on the arts in a year and the equivalent of Nigeria�� federal budget for 2013.��/p>

While public debates about guns focus mostly on their use for personal defense, hunting actually drives the industry�� economic health.

Hunters spend billions each year

The National Shooting Sports Foundation outlined the contribution hunters make to conservation and the economy in its 2013 report, �� Profile of Today�� Hunter.��For example, the NSSF says hunters spent $790 million on license fees in 2011, the most recent year for which data is available.

Top 10 Diversified Bank Stocks To Watch Right Now: ChemoCentryx Inc (CCXI)

ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. The Company targets the chemokine system, a network of molecules, including chemokine ligands and their associated receptors, as well as related chemo-attractant receptors, all of which are known to drive inflammation. As of December 31, 2011, the Company had four drug candidates in clinical development. Its drug candidates include Traficet-EN (CCX282, GSK'786 or vercirnon), CCX140, CCX354, CCX168, CCX872, CCX507 and CCX662. The Company is also advancing several additional independent drug candidates through preclinical development. The Company�� wholly owned subsidiary is ChemoCentryx Limited.

The Company's drug candidate Traficet-EN (CCX282, GSK'786), is to control the inflammatory response underlying IBD by targeting the chemokine receptor known as CCR9. The Company has completed nine clinical trials with Traficet-EN in a total of 785 subjects, including five Phase I clinical trials (three in the United States and two in the United Kingdom), one thorough QT study in the United States (an assessment of cardiovascular safety which is required for regulatory approval), and three Phase II clinical trials (one in the Netherlands, the United Kingdom, and the United States, one in Finland and one (PROTECT-1) in Australia, Austria, Belgium, Brazil, Bulgaria, Canada, the Czech Republic, Denmark, France, Germany, Hungary, Israel, the Netherlands, Poland, South Africa, Sweden and the United Kingdom). As of December 31, 2011, the Company�� Traficet-EN drug candidate is in four pivotal Phase III clinical trials being conducted by its partner Glaxo Group Limited (GSK).

The Company's independent drug candidate CCX140, targets the chemokine receptor known as CCR2. CCX140 is a potent and selective antagonist of CCR2 that is found on subsets of monocytes and macrophages, which are cells of th! e immune system. In January 2011, the Company completed a 159-patient randomized Phase II clinical trial, conducted in Australia, the Czech Republic, Germany, Hungary and New Zealand, to assess the safety and tolerability of CCX140 in patients with type 2 diabetes. In addition, CCX140 demonstrated biological activity through a dose-dependent decrease in fasting plasma glucose.

CCX354 targets the chemokine receptor known as CCR1. Synovial fluid from the joints of rheumatoid arthritis (RA) patients contains high levels of activated CCR1 chemokine ligands. The Company completed two Phase I clinical trials in a total of 84 healthy subjects, conducted in Switzerland followed by a Phase I/II clinical trial in 24 patients with stable RA, conducted in Belgium and Romania, and a Phase II proof-of-concept clinical trial in 160 patients with moderate-to-severe RA, conducted in Belgium, the Czech Republic, Germany, Hungary, Poland, Romania and the Ukraine. GSK exercised its option to further develop and commercialize CCX354 in November 2011 and had an exclusive right to initiate a Phase II b clinical trial for CCX354 in RA.

CCX168 targets the chemo-attractant C5a receptor (C5aR), which binds to a biologically activated fragment of the complement protein known as C5. As of December 31, the Company completed a Phase I clinical trial for CCX168, conducted in Switzerland. The Company initiated a Phase II proof-of-concept clinical trial in AAV in the fourth quarter of 2011. Its CCX872 is an independent next generation CCR2 drug candidate for the treatment of metabolic diseases, its CCX507 is an independent drug candidate for the treatment of inflammatory bowel disease (IBD) and CCX662 is an independent drug candidate for the treatment of glioblastoma multiforme (GBM).

The Company competes with Abbott Laboratories, Amgen Inc, AstraZeneca plc, Biogen Idec Inc, Bayer AG, Elan Corporation plc, Glaxo Group Limited, Merck & Co Inc, Merck Serono, Takeda Pharmaceutical Co Ltd, Novartis AG! , Pfizer ! Inc, Reata Pharmaceuticals, Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb, Incyte Corp and UCB Pharma.

Advisors' Opinion:

• [By CRWE]

  ChemoCentryx, Inc. (Nasdaq:CCXI), reported that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the BioCentury NewsMakers in the Biotech Industry Conference on Friday, September 7, 2012, at 9:30 a.m. Eastern Time at the Millennium Broadway Hotel & Conference Center in New York, NY.

• [By James E. Brumley]

  The last few weeks haven't been particularly encouraging for Crohn's disease sufferers. In August, GlaxoSmithKline (NYSE: GSK) and ChemoCentryx (NASDAQ:CCXI) reported that a jointly-developed Crohn's drug, vercirnon, had failed to meet its late-stage trial endpoints. Though the in-development drug isn't dead in the water (GSK and CCXI could rework the drug, the testing regimen, or use it for other indications), it doesn't look good. Then this month - just a few days ago - Coronado Biosciences Inc. (NASDAQ:CNDO) reported that its Phase 3 trials of Crohn's disease drug TSO had also failed to meet its primary endpoints as well. Like vercirnon, CNDO isn't completely out of luck here with the treatment, but forging ahead with further development of the treatment is grasping at straws. Crohn's sufferers don't need to give up home just yet, however - TNI Biotech Inc. (OTCMKTS:TNIB) appears to have a Crohn's treatment that works, and should be able to sidestep the problems that plagued ChemoCentryx, GlaxoSmithKline, and Coronado Biosciences.

Top 10 Diversified Bank Stocks To Watch Right Now: California Grapes International Inc (CAGR)

California Grapes International, Inc., formerly China Food Services, Corp., incorporated in 1992, conducts its primary business operations as an importer, exporter and distributor of staple, organic, specialty, and gourmet foods and beverages, catering to the Asian Pacific Rim. The Company owns and operates Golden Dragon Food & Beverage Import & Export Company of Hong Kong, Ltd. (GDHK) in central Hong Kong and Beijing Flying Golden Dragon International Trading Co., Ltd. in China (BFGD). Golden Dragon Holdings, Inc. has agreements with the United State food manufacturers. It acts as a buying agent for GDHK, negotiating vendor contracts and services with the United States food and beverage industry partners.

The Company focuses to offer wholesale food distribution to grocery chains and independent food stores throughout China. The Company focuses on purchasing goods directly from manufactures in the United States, Latin America and Europe, and distributes these products to distributors, grocery stores, supermarkets and hypermarkets throughout China.

Advisors' Opinion:

• [By abirk]

  The smokeable products category (cigarettes and cigars) has grown income at a compounded annual growth rate (CAGR) of 4.2%. In 2013, income from smokeable products was $6.4 billion, up from $5.2 billion in 2008.

• [By Sam Stovall]

  1) He could have owned the S&P 500 all year long from April 30, 1990 through October 25, 2013. He would have earned a compound annual growth rate (CAGR) of 8.0%, excluding dividends reinvested.

Top Solar Stocks For 2015: Unilever PLC(UL)

Unilever PLC operates as a fast-moving consumer goods company in Asia, Africa, Europe, and the Americas. It offers personal care products, including skin care and hair care products, deodorants, and oral care products under the brand names of Axe, Brylcreem, Dove, Fissan, Lifebuoy, Lux, Pond's, Radox, Rexona, Signal & Close Up, Simple, St Ives, Sunsilk, TRESemm� Vaseline, and VO5. The company also provides home care products comprising laundry tablets, powders and liquids, soap bars, and a range of cleaning products under the Cif, Comfort, Domestos, Omo, Radiant, Sunlight, and Surf brand names. In addition, it offers food products consisting of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads, as well as cooking products, such as liquid margarines. The company markets its food products under the brand names of Becel/Flora, Bertolli, Blue Band, Rama, Hellmann?s, Amora, and Knorr. Further, it provides refreshment products, which includ e ice cream, tea-based beverages, weight-management products, and nutritionally enhanced staples under the brand names of Heartbrand, Lipton, and Slim Fast. Unilever sells its products through its own sales force, as well as through independent brokers, agents, and distributors to chain, wholesale, co-operative and independent grocery accounts, food service distributors, and institutions. The company, formerly known as Lever Brothers Limited, was founded in 1885 and is based in London, the United Kingdom. Unilever PLC is a subsidiary of The Unilever Group.

Advisors' Opinion:

• [By Eric Volkman]

  Unilever (NYSE: UL  ) has strengthened its stake in one of its subsidiaries abroad. The company announced that its tender offer for the shares of Hindustan Unilever closed today, with the result that the consumer goods multinational now owns 67.3% of the company. This is a gain of nearly 15 percentage points over the pre-offer figure of nearly 52.5%.�

• [By Royston Wild]

  I am currently looking at the dividend prospects of�Unilever� (LSE: ULVR  ) (NYSE: UL  ) and assessing whether the company is an appetizing pick for income investors.

• [By Jill Ralph]

  I've put popular U.K. share Unilever (LSE: ULVR  ) (NYSE: UL  ) under the microscope for today. I'm going to zoom in on three key things to know -- and in this case, like -- about a company that makes many of the products you and I keep in our cupboards.

• [By Eric Volkman]

  Unilever (NYSE: UL  ) is making a play to enlarge its presence in India. It has launched an open offer to buy out shareholders in that country's Hindustan Unilever for 600 rupees ($10.02) per share. The offer comes in force on June 21, and will end on July 4.

Top 10 Diversified Bank Stocks To Watch Right Now: Cleantech Solutions International Inc (CLNT)

Cleantech Solutions International, Inc., incorporated on June 24, 1987, manufactures and sells forged products and fabricated products to a range of clean technology customers, including forged rolled rings and related products for the wind power industry and other industries and equipment to the solar industry. The Company also makes textile dyeing and finishing machines. The Company is owner of Fulland Limited (Fulland). Fulland owns 100% of Green Power Environment Technology (Shanghai) Co., Ltd. (Green Power) and Wuxi Fulland Wind Energy Equipment Co., Ltd. (Fulland Wind Energy), which are wholly foreign-owned enterprises (WFOE) organized under the laws of the People�� Republic of China. Green Power is a party to a series of contractual arrangements with Wuxi Huayang Electrical Power Equipment Co., Ltd. (Electrical) and Wuxi Huayang Dyeing Machinery Co., Ltd. (Dyeing). Dyeing produces and sells a range of high and low temperature dyeing and finishing machinery for the textile industry. The Company refers to this segment as the dyeing division. The Company is engaged in two business segments: the forged rolled rings and related components segment, in which it manufacture and sell forged rolled rings, yaw bearings and shafts, and other forged components for the wind power and other industries, as well as equipment for the solar power industry, and the dyeing and finishing equipment segment, in which it manufactures and sell textile dyeing and finishing machines.

Forged Rolled Rings and Related Components Segment

The Company produces precision forged rolled rings and other forged components to the wind and other industries. Forged rolled rings and other forged components for the wind industry are used in wind turbines, which are used to generate wind power. It also manufactures shafts and forged rolled rings for gear rims, flanges and other applications. In addition to the wind industry, it sells its forged rolled rings and other forged components in other industries, inclu! ding heavy machinery manufacturing, petrochemical, metallurgical, sea port machinery, defense and radar manufacturing industries, which uses its forged rolled rings railway as components in the manufacture of equipment. It produces precision forgings using axial close-die forging technology, which is a technology for producing rotary precision forgings, using forging equipment, which it manufactured for its own use.

During the year ended December 31, 2011, the Company manufactured and delivered test subassemblies for solar cell manufacturing equipment, which marked its entry into the solar products market. It supplies solar components used in production of multi crystalline and mono crystalline silicon wafers. Solar industry capabilities include the manufacture of complex pressure vessels and chamber, high temperature vessels, and thick-walled vessels. Its forged rolled rings and other related products are sold for use by manufacturers of industrial equipment.

The Company competes with Wuxi Dachang Group.

Dyeing and Finishing Equipment Segment

Through the Company�� dyeing and finishing segment, it designs, manufactures and distributes a range of high and low temperature dyeing and finishing machinery. Its products feature both automation and mechanical-electrical integration. Its products are used in dyeing yarns, such as pure cotton, cotton-polyester, terylene, polyester wool, poly-acrylic fiber, nylon, cotton ramie, and wool yarn.

The Company competes with Fong�� National Engineering (Shenzhen) Co., Ltd.

Advisors' Opinion:

• [By Roberto Pedone]

  Another basic materials player that looks ready to trigger a major breakout trade is Cleantech Solutions (CLNT), which manufactures and sells high-precision forged rolled rings, yaw bearings and shafts. It also manufactures and sells textile dyeing and finishing machines. This stock is off to a strong start in 2013, with shares up 58%.

  If you take a look at the chart for Cleantech Solutions, you'll notice that this stock has been uptrending for the last two months and change, with shares moving higher from its low of $4.82 to its recent high of $7.04 a share. During that uptrend, shares of CLNT have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CLNT within range of triggering a major breakout trade.

  Traders should now look for long-biased trades in CLNT if it manages to break out above some near-term overhead resistance levels at $6.68 to $7.04 a share, and then once it takes out more resistance at $7.79 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 758,917 shares. If that breakout hits soon, then CLNT will set up to re-test or possibly take out its next major overhead resistance levels at $9 to $10 a share.

  Traders can look to buy CLNT off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $5.67 a share, or around more support at $5 a share. One could also buy CLNT off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Diversified Bank Stocks To Watch Right Now: Bio-Reference Laboratories Inc.(BRLI)

Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area. It offers various chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology, and other tissue analysis. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems. In addition, it operates a Web-based connectivity portal solution for laboratories and physicians to provide laboratory ordering and results to physician customers. The company provides its services directly to physicians, geneticists, hospitals, clinics, and correctional and other health facilities. Bio-Refe rence Laboratories, Inc. was founded in 1981 and is headquartered in Elmwood Park, New Jersey.

Advisors' Opinion:

• [By Ben Levisohn]

  As a result, LabCorp has dropped 11% to $87.79 and has helped drag down competitors like Quest Diagnostics (DGX), and BioReference Laboratories (BRLI).

Top 10 Diversified Bank Stocks To Watch Right Now: Huaneng Power International Inc (HNP)

Huaneng Power International, Inc. is principally engaged in the investment, construction, operation and management of power plants. The Company�� electricity generation business covers Northeast China Grid, North China Grid, Northwest China Grid, East China Grid, Central China Grid and South China Grid, as well as grid in Singapore. The Company�� power plants are mainly located in Shandong province, Liaoning province, Zhejiang province, Guangdong province, Jiangsu province, Hebei province, Fujian province, Jiangxi province, Chongqing city, Gansu province, Beijing city and Shanghai city, among others. As of December 31, 2010, the Company had a wholly owned power operation subsidiary in Singapore.

The Company�� Huaneng Dalian Power Plant (Dalian Power Plant) is located on the outskirts of Dalian, on the coast of Bohai Bay. Dalian Power Plant, including Phase I and Phase II, has an installed capacity of 1,400 megawatts and consists of four 350 megawatts coal-fired units. Dalian Power Plant typically stores 200,000 tons of coal onsite. Dalian Power Plant sells all its electricity through the Liaoning Electric Power Co., Ltd. and the Northeastern Power Grid. Electricity generated by Dalian Power Plant is delivered to the Liaoning Provincial Power Grid. Huaneng Dandong Power Plant (Dandong Power Plant) is located on the outskirts of the city of Dandong in Liaoning. Dandong Power Plant comprises two 350 megawatts coal-fired units. All the electricity generated by Dandong Power Plant is delivered to the Liaoning Provincial Power Grid and is sold through the Liaoning Electric Power Co., Ltd. and the Northeastern Power Grid.

Huaneng Yingkou Power Plant (Yingkou Power Plant) is located in Yingkou City in Liaoning Province. Yingkou Power Plant Phase I has an installed capacity of 640 megawatts and consists of 2x320 megawatts supercritical coal-fired generating units. Yingkou Power Plant sells all its electricity through Liaoning Electric Power Co., Ltd. and the Northeastern Power ! Grid. Electricity generated by Yingkou Power Plant is delivered to the Liaoning Provincial Power Grid. The Company�� construction projects in the Liaoning Province include the Yingkou Power Plant Phase II, which is planned to consist of two 600 megawatts coal-fired generating units. The Company owns 100% equity interests in this project.

Power Plant in Fujian Province

The Company�� Huaneng Fuzhou Power Plant (Fuzhou Power Plant) is located on the south bank of the Min River, southeast of the city of Fuzhou. Fuzhou Power Plant, including Phase I and Phase II, has an installed capacity of 1,400 megawatts and consists of four 350 megawatts coal-fired units. All the electricity sales of Fuzhou Power Plant are made through the Fujian Electric Power Company, Ltd. Electricity generated by Fuzhou Power Plant is delivered to the Fujian Provincial Power Grid.

Power Plant in Hebei Province

Huaneng Shangan Power Plant (Shangan Power Plant) is located on the outskirts of Shijiazhuang. Shangan Power Plant has been developed in two separate expansion phases. The Shangan Power Plant Phase I has an installed capacity of 700 megawatts and consists of two 350 megawatts coal-fired units. Shangan Power Plant sells all its electricity through the Hebei Electric Power Corporation. Electricity generated by Shangan Power Plant is delivered to the Hebei Provincial Power Grid. Shangan Power Plant Phase III is planned to consist of two 600 megawatts coal-fired generating units. The Company owns 100% equity interests in this project.

Power Plants in Jiangsu Province

Huaneng Nantong Power Plant (Nantong Power Plant) is located in the city of Nantong. Nantong Power Plant, including Phase I and Phase II, has an installed capacity of 1,404 megawatts, and consists of two 352 megawatts and two 350 megawatts coal-fired units. Nantong Power Plant sells all its electricity through the Jiangsu Electric Power Company. Electricity generated by Nantong Power Pl! ant is de! livered to the Jiangsu Provincial Power Grid. The Company�� Huaneng Nanjing Power Plant (Nanjing Power Plant) has an installed capacity of 640 megawatts consisting of two 320 megawatts coal-fired units.

The Huaneng Taicang Power Plant (Taicang Power Plant) is located in the vicinity of Suzhou, Wuxi and Changzhou in the Jiangsu Province. Taicang Power Plant is an ancillary facility of the China-Singapore Suzhou Industrial Park and has a total planned capacity of 1,200 megawatts. Taicang Power Plant Phase I consists of 2 x 300 megawatts coal-fired generating units. Taicang Phase II Expansion consists of two 600 megawatts coal-fired generating units. The Huaneng Huaiyin Power Plant (Huaiying Power Plant) is located in the Centre of the Northern Jiangsu Power Grid. The plant has 2 x 220 megawatts coal-fired generating units.

Power Plants in Shanghai Municipality

Huaneng Shanghai Shidongkou First Power Plant (Shidongkou I) is located in the northern region of the Shanghai Power Grid. The plant comprises 3 x 325 megawatts, 1 x 300 and 1 x 320 coal-fired generating units, and has a total installed capacity of 1,270 megawatts. Electricity generated by Shidongkou I is delivered to the Shanghai Municipal Power Grid. Huaneng Shanghai Shidongkou Second Power Plant (Shidongkou II) is located in the northern suburbs of Shanghai. Shidongkou II has an installed capacity of 1,200 megawatts and consists of two 600 megawatts coal-fired supercritical units.

Power Plants in Guangdong Province

Located on the outskirts of the city of Shantou, the Huaneng Shantou Oil-Fired Power Plant (Shantou Power Plant) was set up with the support of the Shantou municipal government and the Guangdong provincial government. In 2007, Shantou Power Plant Phase I consisted of two 300 megawatts coal-fired units. The Company�� construction project in Guangdong Province consists of the Huaneng Haimen Power Plant (Haimen Power Plant), which is planned to consist of two 1,000 mega! watts gen! erating units with a total installed capacity of 2,000 megawatts. The Company owns 100% equity interest in this project.

Power Plants in Shandong Province

Huaneng Dezhou Power Plant (Dezhou Power Plant) is located in Dezhou City, near the border between Shandong and Hebei Provinces. Dezhou Power Plant consists of three Phases, with Phases I consisting of one 320 megawatts and one 330 megawatts coal-fired generating units, Phase II consisting of two 300 megwatts coal-fired generating units, and Phase III consisting of two 700 megawatts coal-fired generating units. Dezhou Power Plant sells its electricity through Shandong Electric Power Corporation. Electricity generated by Dezhou Power Plant is delivered to the Shandong Provincial Power Grid. Huaneng Jining Power Plant (Jining Power Plant) is located in Jining City, near the Jining load Centre and near numerous coal mines.

Huaneng Weihai Power Plant (Weihai Power Plant) is located approximately 16 kilometers southeast of Weihai City, on the shore of the Bohai Gulf. The Company holds a 60% interest in Weihai Power Plant, the remaining 40% interest of which is owned by Weihai Power Development Bureau (WPDB). Weihai Power Plant, developed in two phases, consists of four coal-fired generating units with an aggregate design capacity of 850 megawatts. Huaneng Xindian Power Plant (Xindian Power Plant) is located in Zibo Municipality of Shandong Province.

Power Plants in Zhejiang Province

Huaneng Changxing Power Plant (Changxing Power Plant) is located at the intersection of Zhejiang Province, Jiangsu Province and Anhui Province. Changxing Power Plant has one 125 megawatts and one 135 megawatts coal-fired generating units. Changxing Power Plant sells its electricity to Zhejiang Provincial Electric Power Company. The Yuhuan Power Plant is located in Taizhou of Zhejiang Province and consists of two 1,000 megawatts ultra-supercritical, coal-fired generating units with a total installed capacity of ! 2,000 meg! awatts.

Power Plant in Shanxi Province

Huaneng Yushe Power Plant (Yushe Power Plant) is located in Yushe County of Shanxi Province. Yushe Power Plant Phase I has an installed capacity of 200 megawatts and consists of two 100 megawatts coal-fired generating units. Yushe Power Plant sells all its electricity through the Shanxi Electric Power Corporation. Electricity generated by Yushe Power Plant is delivered to the Shanxi Provincial Power Grid.

Power Plant in Henan Province

Qinbei Power Plant is located in Jiyuan Municipality of Henan Province. Its installed capacity is 2,400 megawatts, which consists of four 600 megawatts supercritical coal-fired generating units.

Power Plant in Jiangxi Province

Huaneng Jinggangshan Power Plant (Jinggangshan Power Plant) is located in Jian City of Jiangxi Province, and has an installed capacity of 600 megawatts and consists of two 300 megawatts coal-fired generating units. Jinggangshan Power Plant sells its electricity through the Jiangxi Electric Power Corporation. Electricity generated by it is delivered to the Jiangxi Provincial Power Grid.

Power Plant in Hunan Province

Huaneng Yueyang Power Plant (Yueyang Power Plant) is located in Yueyang City of Hunan Province. Yueyang Power Plant Phase I has an installed capacity of 725 megawatts and consists of two 362.5 megawatts sub-critical, coal-fired generating units. Yueyang Power Plant Phase II consists of two coal-fired generating units with installed capacity of 600 megawatts. Yueyang Power Plant sells its electricity through the Hunan Electric Power Corporation. Electricity generated by Yueyang Power Plant is delivered to the Hunan Provincial Power Grid.

Power Plant in Chongqing Municipality

Huaneng Luohuang Power Plant (Luohuang Power Plant) is located in Chongqing Municipality. Each of Phase I and Phase II of Luohuang Power Plant has an installed capacity of 720 megawatts and consists ! of two 36! 0 megawatts coal-fired generating units. Luohuang Power Plant Phase III consists of two 600 megawatts coal-fired generating units with an installed capacity of 1,200 megawatts.

Power Plant in Gansu Province

Huaneng Pingliang Power Plant (Pingliang Power Plant) is located in Pingliang City of Gansu Province. It has an installed capacity of 1,200 megawatts and consists of four 300 megawatts coal-fired generating units.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Friday morning, the utilities sector proved to be a source of strength for the market. Leading the sector was strength from Huaneng Power International (NYSE: HNP) and Exelon (NYSE: EXC). In trading on Friday, telecommunications services shares were relative laggards, down on the day by about 0.01 percent.

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Friday morning, the utilities sector proved to be a source of strength for the market. Leading the sector was strength from Huaneng Power International (NYSE: HNP) and Pure Cycle (NASDAQ: PCYO). In trading on Friday, healthcare shares were relative laggards, down on the day by about 0.28 percent.

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Utilities stocks gained Friday, with Korea Electric Power (NYSE: KEP) leading advancers. Meanwhile, gainers in the sector included Huaneng Power International (NYSE: HNP), with shares up 2.1 percent, and Pampa Energia SA (NYSE: PAM), with shares up 2.5 percent.

• [By Jake L'Ecuyer]

  Utilities sector gained 0.78 percent in the US market today. Among the utilities stocks, Huaneng Power International (NYSE: HNP) was down more than 1.4 percent, while UIL Holdings (NYSE: UIL) tumbled around 0.7 percent.

Top 10 Diversified Bank Stocks To Watch Right Now: Anika Therapeutics Inc.(ANIK)

Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company offers orthobiologics products for providing relief from the pain of osteoarthritis, and regenerating damaged tissue, such as cartilage defects; ORTHOVISC for the treatment of osteoarthritis of the knee and various joints; ORTHOVISC mini for the treatment of osteoarthritis in small joints; and MONOVISC, a single injection product used for the treatment of osteoarthritis in various joints. It also provides wound care products that comprise Hyalograft 3D for the regeneration of skin; and Hyalomatrix for the treatment of burns and ulcers. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, Optivisc, and AnikaVisc which are injectable HA products used as viscoelastic agents in o phthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides INCERT, a HA based product for the prevention of post-surgical adhesions; Hyalobarrier and Hyalobarrier Endo, which are post operative adhesion barriers for abdominal indications; and HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis. Additionally, the company offers Merogel, a product used for the treatment of ear, nose, and throat disorders; and provides dermal fillers for facial wrinkles and scar remediation under the ELEVESS and HYDRELLE brand names. It markets its products directly, as well as through a network of distributors primarily in the United States and Europe. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

Advisors' Opinion:

• [By STOCKPICKR]

   

  Anika Therapeutics (ANIK), together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair in the U.S., Europe, and internationally. This stock closed up 2.1% to $48.86 in Monday's trading session.

   

  Monday's Volume: 1.25 million
  
  Three-Month Average Volume: 347,160
  
  Volume % Change: 272%

   

  From a technical perspective, ANIK jumped higher here right above some near-term support at $46 with above-average volume. This spike higher on Monday briefly pushed shares of ANIK into breakout territory, since the stock flirted with some near-term overhead resistance levels at $49.21 to $49.37. Shares of ANIK tagged an intraday high of $51.40, before it closed below that level at $48.86. Market players should now look for a continuation move to the upside in the short-term if ANIK manages to take out Monday's high of $51.36 to its 52-week high of $52.49 with high volume.

   

  Traders should now look for long-biased trades in ANIK as long as it's trending above Monday's low of $47.57 or above $46 and then once it sustains a move or close above $51.36 to $52.49 with volume that hits near or above 347,160 shares. If that move begins soon, then ANIK will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $55 to $60.

   

Top 10 Diversified Bank Stocks To Watch Right Now: Roper Industries Inc.(ROP)

Roper Industries, Inc. designs, manufactures, and distributes radio frequency (RF) products and services, industrial technology products, energy systems and controls, and medical and scientific imaging products and software. Its Medical and Scientific Imaging segment offers patient positioning devices, 3-D measurement technology, diagnostic and therapeutic disposable products, ultrasound bladder volume measurement instruments, and video laryngoscopes; digital imaging products and software; and handheld and vehicle mount computers and software. The company?s Energy Systems and Controls segment produces control systems, fluid properties testing equipment, industrial valves and controls, sensors and controls, and non-destructive inspection and measurement products and solutions. Its Industrial Technology segment produces water and fluid handling pumps, equipment and consumables, leak testing equipment, flow measurement and metering equipment, water meter, and automatic meter reading products and systems. The company?s RF Technology segment provides radio frequency identification communication technology and software solutions that are used in toll and traffic systems and processing; security and access control; campus card systems; software-as-a-service in the freight matching and food industries; and metering and remote monitoring applications. It markets its products to RF applications, medical, water, energy, research, education, software-as-a-service-based information networks, and security markets. The company distributes its products through direct sales personnel, manufacturers? representatives, value added resellers, original equipment manufacturers, and distributors. It principally operates in the United States, Canada, Asia, Europe, the Middle East, and South America. Roper Industries, Inc. was founded in 1981 and is based in Sarasota, Florida.

Advisors' Opinion:

• [By Seth Jayson]

  Roper Industries (NYSE: ROP  ) reported earnings on April 29. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), Roper Industries missed estimates on revenues and beat expectations on earnings per share.

• [By Marc Bastow]

  Radio frequency products manufacturer and distributor Roper (ROP) raised its quarterly dividend 21% to 20 cents per share, payable on Jan. 14 to shareholders of record as of Jan. 10. This marks the 21st consecutive rise in Roper’s annual dividend.
  ROP Dividend Yield: 0.6%

• [By Rich Duprey]

  It's a bit incongruous, but industrial manufacturing specialist Roper� (NYSE: ROP  ) is now the proud owner of Managed Health Care Associates, a New Jersey-based supplier of services for�alternate site health-care providers.�The transaction was valued at approximately $1 billion, and was funded from Roper's�available cash and borrowings under its credit facility.

• [By Lauren Pollock]

  Among the companies with shares expected to actively trade in Monday’s session are Merck(MRK) & Co., Biogen Idec Inc.(BIIB) and Roper Industries Inc.(ROP)

Top 10 Diversified Bank Stocks To Watch Right Now: Sinclair Broadcast Group Inc.(SBGI)

Sinclair Broadcast Group, Inc., a television broadcasting company, owns or provides certain programming, operating, or sales services to television stations in the United States. The company broadcasts free over-the-air programming, such as network provided programs, news produced locally, local sporting events, programming from program service arrangements, and syndicated entertainment programs. It owns or provides programming and operating services pursuant to local marketing agreements, or provides sales services pursuant to outsourcing agreements to 58 television stations in 35 markets. The company was founded in 1952 and is based in Hunt Valley, Maryland.

Advisors' Opinion:

• [By Dan Radovsky]

  Sinclair Broadcast Group (NASDAQ: SBGI  ) says it is on its way to becoming the nation's largest television broadcasting company if a� definitive agreement it signed with the Allbritton family comes to fruition, according to an announcement today by Sinclair.

• [By Jesse Solomon]

  The Sinclair Broadcast Group (SBGI), which owns and operates almost 170 stations and reaches roughly 40% of all U.S. television households, shot up 15% after the ruling.

Top 10 Diversified Bank Stocks To Watch Right Now: ProShares Trust II (YCS)

ProShares Trust II (the Trust) is a statutory trust organized into separate series. The Trust offers seven Funds. The Trust offers beneficial interest in each of its 24 series. The 24 separate series include ProShares Ultra DJ-UBS Commodity, ProShares UltraShort DJ-UBS Commodity, ProShares Ultra DJ-UBS Crude Oil, ProShares UltraShort DJ-UBS Crude Oil, ProShares Ultra DJ-UBS Natural Gas, ProShares Short DJ-UBS Natural Gas, ProShares UltraShort DJ-UBS Natural Gas, ProShares Short Gold, ProShares Ultra Gold, ProShares UltraShort Gold, ProShares Ultra Silver, ProShares UltraShort Silver, ProShares Ultra Euro, ProShares UltraShort Euro, ProShares Ultra Yen ProShares UltraShort Yen, ProShares Ultra VIX Short-Term Futures ETF, ProShares VIX Short-Term Futures ETF, ProShares Short VIX Short-Term Futures ETF, ProShares UltraShort VIX Short-Term Futures ETF, ProShares Ultra VIX Mid-Term Futures ETF, ProShares VIX Mid-Term Futures ETF, ProShares Short VIX Mid-Term Futures ETF and ProShares UltraShort VIX Mid-Term Futures ETF.

The Funds offer investors the opportunity to obtain leveraged, inverse or inverse leveraged exposure to a particular benchmark. The Funds include funds linked to futures-based commodity indexes (the Commodity Index Funds), particular commodities (the Commodity Funds) or particular currencies (the Currency Funds). ProShare Capital Management LLC serves as the Trust�� Sponsor, commodity pool operator and commodity trading advisor. Wilmington Trust Company is the sole Trustee of the Trust.

Dow Jones-UBS Commodity Index

ProShares Ultra DJ-UBS Commodity and ProShares UltraShort DJ-UBS Commodity are designed to track a multiple or an inverse multiple of the daily performance of the Dow Jones-UBS Commodity IndexSM. The Dow Jones-UBS Commodity IndexSM (the Dow Jones-UBS) is designed to be a highly liquid and diversified benchmark for the commodity futures market. It focuses to reflect the overall commodity sector by measuring the performance of commodity fu! tures contracts. The Dow Jones-UBS is a rolling index, which means that the Dow Jones-UBS does not take actual physical possession of any commodities; rather, it tracks a rolling futures position. An investor with a rolling futures position is able to avoid delivering (or taking delivery of) underlying physical commodities while maintaining exposure to those commodities. The roll for each Index component occurs over a period of five Dow Jones-UBS business days in certain months according to a pre-determined schedule. The exact roll methodology differs between certain commodities. The Index will reflect the performance of its underlying commodities, including roll costs, without regard to income earned on cash positions. The Dow Jones-UBS is consisted of eight different commodity sectors, such as petroleum, natural gas, livestock, grains, industrial metals, precious metals, softs and vegetable oils. These eight sectors track futures contracts prices of 19 specific commodities, such as natural gas, crude oil, unleaded gasoline, heating oil, live cattle, lean hogs, wheat, corn, soybeans, soybean oil, aluminum, copper, zinc, nickel, gold, silver, sugar, cotton and coffee. The Dow Jones-UBS is consisted of commodities traded on the United States exchanges, with the exception of aluminum, nickel and zinc, which trade on the London Metal Exchange.

Dow Jones-UBS Natural Gas Subindex

ProShares Ultra DJ-UBS Natural Gas and ProShares UltraShort DJ-UBS Natural Gas are designed to track twice (2x) or twice the inverse (-2x) of the daily performance of the Dow Jones-UBS Natural Gas SubindexSM, respectively The Dow Jones-UBS Natural Gas SubindexSM is intended to reflect the performance of a rolling position in natural gas futures contracts traded on the NYMEX without regard to income earned on cash positions. An investment in natural gas futures contracts may often perform very differently than the price of physical natural gas.

Advisors' Opinion:

• [By Ben Levisohn]

  The euro has dropped about 0.8% against the dollar, while the CurrencyShares Euro Trust ETF (FXE) has dropped 0.7% to $136.71 and the Currency Shares Japanese Yen Trust ETF (FXY) has fallen 1%. The ProShares UltrasShort Euro ETF (EUO) has gained 1.3% to $16.77, while the ProShares UltraShort Yen (YCS) has gained 1.9% to $66.58.

• [By Charles Sizemore]

  As always, use common sense when trading. You can be ��ight��about a short and still lose a lot of money if you get caught on the wrong side of a short squeeze. An ETF option to consider in lieu of shorting the yen directly would be the ProShares Ultrashort Yen (YCS).

• [By Anthony Mirhaydari]

  Today, the yen carry trade, as represented by the ProShares UltraShort Yen (YCS) , is collapsing below both its lower Bollinger Band and its 50-day moving average ��the most significant downtrend initiation since June. The scramble to cover positions funded by yen carry trades is why the selling is so frantic.

• [By MONEYMORNING]

  Split your capital in two halves. With one half, buy ProShares UltraShort Yen (NYSE Arca: YCS), and with other half, buy shares of AMLP, simple and clean.